2Malinow MR, Bostom AG, Krauss RM. Hommcysteine, diet and cardiovascular diseases: a statenent for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation, 1999,99:178-182.
3MeQuillan BM,Beilby JP,Nidorf M,et al. Hyperhomocysteinemia but not the C667T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. Circulation, 1999,99: 2383-2388.
4Tsai MY,Welge BG,Hanson NQ,et al. Genetic causes of mild hypethomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis, 1999,143:163-170.
5Brouwer DA J, Weliten HE, Reingeud DJ, et al. Plasma folic acid cutoff value, derived from its relationship with homocysteine. Clin Chem, 1998,44: 1545-1550.
6Wald NE, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease:results of a prospective study with implications regarding prevention. Arch Intern Med, 1998,158:862-867.
7Bostom AG, Silbershatz H, Rosenbery IH, et al. Nonfasting plasma total homocysteine levels and allcause and coronary artery disease mortaliey in elder framingham men and women. Arch Intem Med, 1999,159:1077-1080.
8Usui M,Matsuoka H,Miyazaki H,et al. Endothelial dysfunction by acute hyperhomo-cysteinemia: restoration by folic acid. Clinical Science, 1999, 96:235-239.
9Chambers JC, McGregor A,Jean-Marie J,et al. Demonstration of rapid onset vascular endothelial dysfuction after hyperhomocysteinemia and effect reversible with vitamin C therapy. Circulation, 1999,99:1156-1160.
10Stühlinger MC,Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine. Circulation, 2001,104: 2569-2574.
二级参考文献1
1Suresh C Tyagi,Lane M Smiley,Vibhas S Mujumdar. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone[J] 1998,Molecular and Cellular Biochemistry(1-2):107～116
